tradingkey.logo

Co-Diagnostics Inc

CODX
0.390USD
-0.016-3.87%
Close 11/10, 16:00ETQuotes delayed by 15 min
14.13MMarket Cap
LossP/E TTM

Co-Diagnostics Inc

0.390
-0.016-3.87%

More Details of Co-Diagnostics Inc Company

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Co-Diagnostics Inc Info

Ticker SymbolCODX
Company nameCo-Diagnostics Inc
IPO dateJul 12, 2017
CEOMr. Dwight H. Egan
Number of employees132
Security typeOrdinary Share
Fiscal year-endJul 12
Address2401 S. Foothill Dr. Suite D
CitySALT LAKE CITY
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code84109
Phone18014381036
Websitehttps://codiagnostics.com/
Ticker SymbolCODX
IPO dateJul 12, 2017
CEOMr. Dwight H. Egan

Company Executives of Co-Diagnostics Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Richard Abbott
Mr. Richard Abbott
President
President
618.65K
+2.30%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
272.50K
+21.56%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
262.50K
+22.57%
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Richard Abbott
Mr. Richard Abbott
President
President
618.65K
+2.30%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
272.50K
+21.56%
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
262.50K
+22.57%
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
No Data
By RegionUSD
Name
Revenue
Proportion
United States
162.91K
0.00%
Rest of the world
0.00
0.00%
By Business
By Region
No Data

Shareholding Stats

Updated: Sat, Sep 20
Updated: Sat, Sep 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Orca Capital GmbH
3.14%
The Vanguard Group, Inc.
2.84%
Private Advisory Group LLC
1.96%
Egan (Dwight H.)
1.24%
Abbott (Richard David)
1.05%
Other
89.77%
Shareholders
Shareholders
Proportion
Orca Capital GmbH
3.14%
The Vanguard Group, Inc.
2.84%
Private Advisory Group LLC
1.96%
Egan (Dwight H.)
1.24%
Abbott (Richard David)
1.05%
Other
89.77%
Shareholder Types
Shareholders
Proportion
Investment Advisor
9.34%
Individual Investor
5.04%
Investment Advisor/Hedge Fund
1.06%
Hedge Fund
0.93%
Research Firm
0.36%
Other
83.27%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
80
7.32M
13.09%
+900.30K
2025Q2
94
8.91M
26.43%
-49.92K
2025Q1
104
8.10M
24.04%
-1.01M
2024Q4
112
7.90M
24.75%
+252.58K
2024Q3
117
6.36M
19.95%
-1.22M
2024Q2
133
6.56M
20.58%
-1.41M
2024Q1
141
5.44M
17.41%
-2.70M
2023Q4
150
5.77M
18.52%
-2.36M
2023Q3
166
5.34M
17.40%
-3.33M
2023Q2
189
5.25M
17.04%
-4.29M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Orca Capital GmbH
2.19M
4.56%
+2.19M
--
Sep 18, 2025
The Vanguard Group, Inc.
1.73M
3.6%
-44.94K
-2.53%
Jun 30, 2025
Private Advisory Group LLC
1.18M
2.45%
--
--
Jun 30, 2025
Egan (Dwight H.)
748.18K
1.55%
+111.64K
+17.54%
May 23, 2025
Abbott (Richard David)
631.47K
1.31%
+12.82K
+2.07%
May 23, 2025
Brown (Brian Lee)
599.30K
1.24%
+86.00K
+16.76%
May 23, 2025
Renaissance Technologies LLC
561.02K
1.17%
+10.70K
+1.94%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
427.44K
0.89%
-69.29K
-13.95%
Jun 30, 2025
Geode Capital Management, L.L.C.
319.99K
0.66%
-22.18K
-6.48%
Jun 30, 2025
Nelson (James B)
272.50K
0.57%
+48.33K
+21.56%
May 23, 2025
View more

Related ETFs

Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI